AtriCure
ATRC
112 hedge funds and large institutions have $351M invested in AtriCure in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 12 closing their positions.
5% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 40
1% less funds holding
Funds holding: 113 → 112 (-1)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
17% less capital invested
Capital invested by funds: $422M → $351M (-$71.3M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.98M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$3.81M |
| 4 |
RCP
Rothschild Capital Partners
New York
|
+$2.78M |
| 5 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$2.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Polar Capital
London,
United Kingdom
|
-$12.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.51M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.3M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.38M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$2.33M |
ATRC Hedge Fund Activity: Q3 2014 in Review
112 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2014, worth a combined $351M — down 17% from $422M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of ATRC and 11 opened new positions — a net loss of 1 holder — while 40 trimmed existing stakes and 42 added.
The largest buyer was Wellington Management Group, adding an estimated $19.3M. The largest seller was Polar Capital, cutting an estimated $12.4M.
- 112 institutional investors held AtriCure (ATRC) as of Q3 2014, down from 113 in Q2 2014.
- Funds reported $351M of AtriCure stock for Q3 2014, down 17% quarter-over-quarter.
- 11 funds opened new AtriCure positions in Q3 2014 and 12 closed out, a net change of -1 holder.
- The largest AtriCure buyer in Q3 2014 was Wellington Management Group, an estimated $19.3M added.
- The largest AtriCure seller in Q3 2014 was Polar Capital, an estimated $12.4M sold.
Based on aggregated 13F filings for Q3 2014.